Deleted Tweets From Scott Gottlieb, R-D.C.
Scott Gottlieb's accounts: SteveFDA
Tracked Between: October 20, 2017-January 20, 2021
SteveFDA (R-D.C.)
@SGottliebFDA
RT @tmprowell: We agree @IMFjimMYELOMA! All papers in @JCO_ASCO issue on modernizing elig criteria have @FDAOncology co-authors:… QT @IMFjimMYELOMA: What happens to these real world patients? They need to be allowed to accrue to cancer clinical trials. https://t.co/YHBJGVf25E)
SteveFDA (R-D.C.)
@SGottliebFDA
RT @AccessibleMeds: We applaud @US_FDA 4 updating Orange Book to include date FDA receives the patent information from the brand co NDA… https://t.co/xtFe8MDKJ8
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SGottliebFDA: #FDA announces important update to how it discloses patent related information on branded drugs; opening way for mo… https://t.co/jY2sUY0pnY
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SGottliebFDA: Going forward, #FDA’s Orange Book will show patent submission dates. FDA is publishing this data to improve transpa… https://t.co/BPOvM1IIlO
SteveFDA (R-D.C.)
@SGottliebFDA
Going forward, #FDA’s Orange Book will show patent submission dates. FDA is publishing this data to improve transpa… https://t.co/BPOvM1IIlO
SteveFDA (R-D.C.)
@SGottliebFDA
#FDA announces important update to how it discloses patent related information on branded drugs; opening way for mo… https://t.co/jY2sUY0pnY
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FDAOncology: #OCEGU17 Final agenda posted for Nov. 28 public workshop. Webcast link available to watch online #blcsm #kcsm https://t.co/pXFzto9XX9
SteveFDA (R-D.C.)
@SGottliebFDA
#FDA continues monitoring safety of medical products long after approval. #Sentinel is key part of those post marke… https://t.co/UVxDdbeKnH
SteveFDA (R-D.C.)
@SGottliebFDA
Public input on #FDA’s Sentinel system is a priority. We’ll discuss the program during our annual workshop Feb 7-8 https://t.co/kW0jiWSNRm
SteveFDA (R-D.C.)
@SGottliebFDA
RT @alikodjakNPR: #FDA and @SGottliebFDA making drug patents and exclusivities more transparent. https://t.co/irpqPGlyBK QT @SGottliebFDA: #FDA is updating its Orange Book policy – It'll now include the date FDA receives patent information from branded c… https://t.co/ycbc1LU3Ux)
SteveFDA (R-D.C.)
@SGottliebFDA
RT @US_FDA: DYK cotton plant parts can be used to feed livestock? Follow FDA staff as they travel to Alabama to visit a cotton… https://t.co/VEfM1hzjvX
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FDAOncology: #SABCS17 - @FDAOncology Director Richard Pazdur to present SABCS 40th Anniversary Award Lecture: Past and Future of… https://t.co/lkbqgjVcWG
SteveFDA (R-D.C.)
@SGottliebFDA
#FDA's new Nicotine Steering Committee will re-evaluate and modernize our approach to development & regulation of n… https://t.co/H2uBQm8X00
SteveFDA (R-D.C.)
@SGottliebFDA
FDA Law Blog on new policy of publishing patent dates in Orange Book: “This is a big – and important – change... No… https://t.co/SrLnP0fTr0
SteveFDA (R-D.C.)
@SGottliebFDA
#FDA issues guidance to implement policy when certain packages are grandfathered from provisions of the Drug Supply… https://t.co/P6u2oYwLKH
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FDA_Drug_Info: Do #generics work the same as brand-name medicines? Yes—find out why. https://t.co/iuNa2J9t5v #DiabetesMonth https://t.co/A7fpU6uubR
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SGottliebFDA: FDA Law Blog on new policy of publishing patent dates in Orange Book: “This is a big – and important – change... No… https://t.co/SrLnP0fTr0
SteveFDA (R-D.C.)
@SGottliebFDA
RT @steveusdin1: FDA smoothing path for generic combo, complex drugs https://t.co/ZP0gHkRIYi
SteveFDA (R-D.C.)
@SGottliebFDA
RT @lauriemcginley2: Still smoking? #FDA @sgottliebFDA are looking for solutions. @lauriemcginley2 https://t.co/RfH51zgr1M
SteveFDA (R-D.C.)
@SGottliebFDA
#FDA paves way for new therapies to help cigarette smokers quit: https://t.co/Ad9vUkRlEN